Why the study?
Does achieving optimal and durable residual mitral regurgitation (rMR ≤ 1+) after MitraClip therapy improve long-term outcomes compared to rMR ≥ 2+ in patients with functional mitral regurgitation?
Does achieving optimal and durable residual mitral regurgitation (rMR ≤ 1+) after MitraClip therapy improve long-term outcomes compared to rMR ≥ 2+ in patients with functional mitral regurgitation?
Achieving and maintaining residual mitral regurgitation ≤ 1+ at 12 months after MitraClip therapy is associated with better long-term outcomes in patients with functional mitral regurgitation.
Durable rMR ≤1+ after MitraClip was associated with better outcomes in functional MR; hypothesis-generating and requires randomized confirmation before guiding practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Reichart et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: